PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of hsresearchLink to Publisher's site
 
Health Serv Res. 1998 April; 33(1): 125–145.
PMCID: PMC1070250

A discrete choice model of drug abuse treatment location.

Abstract

OBJECTIVE: To identify short-term drug abuse treatment location risk factors for ten large, self-insured firms starting January 1, 1989 and ending December 31, 1991. DATA SOURCES/STUDY SETTING: Study population selected from a large database of health insurance claims for all treatment events starting January 1, 1989 and ending December 31, 1991. STUDY DESIGN: A nested binomial logit method is used to estimate firm-specific patterns of treatment location. The differences in treatment location patterns among firms are then decomposed into firm effects (holding explanatory variables constant among firms) and variable effects (holding firm-specific parameters constant). PRINCIPAL FINDINGS: Probability of inpatient drug treatment is directly related to the type of drug diagnosis. The most important factors are diagnoses of drug dependence (versus drug abuse) and/or a cocaine dependence. Firm-specific factors also make a substantive difference. Controlling for patient risk factors, firm-specific probabilities of inpatient treatment vary by as much as 87 percent. Controlling for practices of firms and their insurance carriers, differing patient risk profiles cause probabilities of inpatient treatment to vary by as much as 69 percent among firms. Use of the outpatient setting increased over the three-year period. CONCLUSIONS: There are two plausible explanations for the findings. First, people beginning treatment later in the three-year period had less severe conditions than earlier cases and therefore had less need of inpatient treatment. Second, drug abuse treatment experienced the same trend toward the increased use of outpatient care that characterized treatment for other illnesses in the 1980s and early 1990s.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Alterman AI, O'Brien CP, McLellan AT, August DS, Snider EC, Droba M, Cornish JW, Hall CP, Raphaelson AH, Schrade FX. Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. J Nerv Ment Dis. 1994 Mar;182(3):157–163. [PubMed]
  • Budde D, Rounsaville B, Bryant K. Inpatient and outpatient cocaine abusers: clinical comparisons at intake and one-year follow-up. J Subst Abuse Treat. 1992 Fall;9(4):337–342. [PubMed]
  • Drake RE, Wallach MA. Substance abuse among the chronic mentally ill. Hosp Community Psychiatry. 1989 Oct;40(10):1041–1046. [PubMed]
  • Garnick DW, Horgan CM, Hendricks AM, Comstock C. Using health insurance claims data to analyze substance abuse charges and utilization. Med Care Res Rev. 1996 Sep;53(3):350–368. [PubMed]
  • Goodman AC, Holder HD, Nishiura E, Hankin JR. A discrete choice model of alcoholism treatment location. Med Care. 1992 Dec;30(12):1097–1110. [PubMed]
  • Goodman AC, Nishiura E, Hankin JR, Holder HD, Tilford JM. Long-term alcoholism treatment costs. Med Care Res Rev. 1996 Dec;53(4):441–464. [PubMed]
  • Higgins ST, Delaney DD, Budney AJ, Bickel WK, Hughes JR, Foerg F, Fenwick JW. A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry. 1991 Sep;148(9):1218–1224. [PubMed]
  • Holder HD, Blose JO. Typical patterns and cost of alcoholism treatment across a variety of populations and providers. Alcohol Clin Exp Res. 1991 Mar;15(2):190–195. [PubMed]
  • Jensen GA, Morrisey MA. Employer-sponsored insurance coverage for alcohol and drug abuse treatment, 1988. Inquiry. 1991 Winter;28(4):393–402. [PubMed]
  • Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994 Jan;51(1):8–19. [PubMed]
  • Miller WR, Hester RK. Inpatient alcoholism treatment. Who benefits? Am Psychol. 1986 Jul;41(7):794–805. [PubMed]
  • Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990 Nov 21;264(19):2511–2518. [PubMed]

Articles from Health Services Research are provided here courtesy of Health Research & Educational Trust